G. Morris, S. Naidu, A. Topham, F. Guiles, Yihuan Xu, P. Mccue, G. Schwartz, P. Park, A. Rosenberg, K. Brill, E. Mitchell (2007)
Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patientsCancer, 110
M. Pegram, A. Lipton, D. Hayes, B. Weber, J. Baselga, D. Tripathy, Debbie Baly, S. Baughman, T. Twaddell, J. Glaspy, D. Slamon (1998)
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 8
M. Shipitsin, Lauren Campbell, P. Argani, S. Weremowicz, Noga Bloushtain-Qimron, Jun Yao, T. Nikolskaya, T. Serebryiskaya, R. Beroukhim, Min Hu, M. Halushka, S. Sukumar, L. Parker, K. Anderson, L. Harris, J. Garber, A. Richardson, S. Schnitt, Y. Nikolsky, R. Gelman, K. Polyak (2007)
Molecular definition of breast tumor heterogeneity.Cancer cell, 11 3
A. D’Andrea, M. Grompe (2003)
The Fanconi anaemia/BRCA pathwayNature Reviews Cancer, 3
P. Fong, D. Boss, T. Yap, A. Tutt, P. Wu, M. Mergui-Roelvink, Peter Mortimer, H. Swaisland, A. Lau, M. O’Connor, A. Ashworth, J. Carmichael, S. Kaye, J. Schellens, J. Bono (2009)
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.The New England journal of medicine, 361 2
S. Agoff, P. Swanson, H. Linden, S. Hawes, T. Lawton (2003)
Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.American journal of clinical pathology, 120 5
(2011)
Neo-adjuvant cisplatin (CDDP) research article The Journal of Clinical Investigation http://www
Lance Miller, J. Smeds, Joshy George, V. Vega, Liza Vergara, Alexander Ploner, Yudi Pawitan, Per Hall, S. Klaar, Edison Liu, Jonas Bergh (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.Proceedings of the National Academy of Sciences of the United States of America, 102 38
B. Hennessy, A. González-Angulo, K. Stemke‐Hale, M. Gilcrease, S. Krishnamurthy, Ju-Seog Lee, J. Fridlyand, A. Sahin, R. Agarwal, C. Joy, Wenbin Liu, D. Stivers, K. Baggerly, M. Carey, A. Lluch, C. Monteagudo, Xiaping He, V. Weigman, C. Fan, J. Palazzo, G. Hortobagyi, L. Nolden, Nicholas Wang, V. Valero, J. Gray, C. Perou, G. Mills (2009)
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.Cancer research, 69 10
Paula Bos, X. Zhang, C. Nadal, Weiping Shu, R. Gomis, D. Nguyen, A. Minn, M. Vijver, W. Gerald, J. Foekens, J. Massagué (2009)
Genes that mediate breast cancer metastasis to the brainNature, 459
Kevin Kwei, Yvonne Kung, K. Salari, Ilona Holcomb, J. Pollack (2010)
Genomic instability in breast cancer: Pathogenesis and clinical implicationsMolecular Oncology, 4
Debra Winkeljohn (2008)
Triple-negative breast cancer.Clinical journal of oncology nursing, 12 6
D. Solit, F. Zheng, M. Drobnjak, P. Münster, B. Higgins, D. Verbel, G. Heller, W. Tong, C. Cordon-Cardo, D. Agus, H. Scher, N. Rosen (2002)
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 5
Kun Yu, Kumaresan Ganesan, Lay Tan, M. Laban, J. Wu, X. Zhao, Hongmin Li, Carol Leung, Yansong Zhu, Chia-Lin Wei, S. Hooi, L. Miller, P. Tan (2008)
A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid CancersPLoS Genetics, 4
Bicalutamide in treating patients with metastatic breast cancer . NIH Web site
M. Press, R. Finn, D. Cameron, A. Leo, C. Geyer, Ivonne Villalobos, Angela Santiago, Roberta Guzman, A. Gasparyan, Yanling Ma, K. Danenberg, Anne-Marie Martin, L. Williams, C. Oliva, S. Stein, R. Gagnon, M. Arbushites, M. Koehler (2008)
HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast CancerClinical Cancer Research, 14
B. Evers, R. Drost, Eva Schut, M. Bruin, Eline Burg, P. Derksen, H. Holstege, Xiaoling Liu, E. Drunen, H. Beverloo, G. Smith, N. Martin, A. Lau, M. O’Connor, J. Jonkers (2008)
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and CisplatinClinical Cancer Research, 14
R. Wiggans, P. Woolley, T. Smythe, D. Hoth, J. Macdonald, L. Green, P. Schein (2004)
Phase-II trial of tamoxifen in advanced breast cancerCancer Chemotherapy and Pharmacology, 3
H. Burstein, A. Elias, H. Rugo, M. Cobleigh, A. Wolff, P. Eisenberg, M. Lehman, B. Adams, C. Bello, S. Deprimo, C. Baum, K. Miller (2008)
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 11
A. Richardson, Z. Wang, Arcangela Nicolo, Xin Lu, Myles Brown, A. Miron, Xiaodong Liao, J. Iglehart, D. Livingston, Shridar Ganesan (2006)
X chromosomal abnormalities in basal-like human breast cancer.Cancer cell, 9 2
R. Neve, K. Chin, J. Fridlyand, Jennifer Yeh, F. Baehner, T. Fevr, Laura Clark, N. Bayani, Jean-Philippe Coppé, F. Tong, T. Speed, P. Spellman, S. Devries, A. Lapuk, Nicholas Wang, W. Kuo, J. Stilwell, D. Pinkel, D. Albertson, F. Waldman, F. McCormick, R. Dickson, Michael Johnson, M. Lippman, S. Ethier, A. Gazdar, J. Gray (2006)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.Cancer cell, 10 6
A. Bhattacharyya, Uy Ear, B. Koller, R. Weichselbaum, D. Bishop (2000)
The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin*The Journal of Biological Chemistry, 275
A. Subramanian, P. Tamayo, V. Mootha, Sayan Mukherjee, B. Ebert, Michael Gillette, A. Paulovich, S. Pomeroy, T. Golub, E. Lander, J. Mesirov (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 102
Joshua Bauer, A. Chakravarthy, Jennifer Rosenbluth, D. Mi, E. Seeley, Nara De, Matos Granja-Ingram, M. Olivares, M. Kelley, I. Mayer, I. Meszoely, J. Means-Powell, Kimberly Johnson, C. Tsai, G. Ayers, M. Sanders, R. Schneider, S. Formenti, R. Caprioli, J. Pietenpol, Corresponding Author (2010)
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and RadiationClinical Cancer Research, 16
S. Monti, P. Tamayo, J. Mesirov, T. Golub (2003)
Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray DataMachine Learning, 52
E. Rakha, S. Elsheikh, Muhammed Aleskandarany, Hany Habashi, A. Green, D. Powe, M. El-Sayed, A. Benhasouna, J. Brunet, L. Akslen, A. Evans, R. Blamey, J. Reis-Filho, W. Foulkes, I. Ellis (2009)
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal SubtypesClinical Cancer Research, 15
K. Chin, S. Devries, J. Fridlyand, P. Spellman, R. Roydasgupta, Wen-Lin Kuo, A. Lapuk, R. Neve, Zuwei Qian, Tom Ryder, F. Chen, H. Feiler, Taku Tokuyasu, Chris Kingsley, S. Dairkee, Zhenhang Meng, Karen Chew, D. Pinkel, Ajay Jain, B. Ljung, L. Esserman, D. Albertson, Frederic Waldman, Joe Gray (2006)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.Cancer cell, 10 6
M. Guarino (2010)
Src signaling in cancer invasionJournal of Cellular Physiology, 223
B. Haffty, Qifeng Yang, M. Reiss, T. Kearney, S. Higgins, J. Weidhaas, L. Harris, W. Hait, D. Toppmeyer (2006)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 36
N. Juul, Z. Szallasi, A. Eklund, Qiyuan Li, R. Burrell, M. Gerlinger, V. Valero, E. Andreopoulou, F. Esteva, W. Symmans, C. Desmedt, Benjamin Haibe-Kains, C. Sotiriou, L. Pusztai, C. Swanton (2010)
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials.The Lancet. Oncology, 11 4
T. Karn, D. Metzler, E. Ruckhäberle, L. Hanker, R. Gätje, C. Solbach, A. Ahr, Marcus Schmidt, U. Holtrich, M. Kaufmann, A. Rody (2010)
Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancerBreast Cancer Research and Treatment, 120
L. Carey, E. Dees, L. Sawyer, Lisa Gatti, D. Moore, F. Collichio, D. Ollila, Carolyn Sartor, M. Graham, C. Perou (2007)
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 13
R. Wiggans, P. Woolley, T. Smythe, D. Hoth, J. Macdonald, L. Green, P. Schein (1979)
Phase-II trial of tamoxifen in advanced breat cancer.Cancer chemotherapy and pharmacology, 3 1
P. Kenny, Genee Lee, C. Myers, R. Neve, J. Semeiks, P. Spellman, Katrin Lorenz, Eva Lee, M. Barcellos-Hoff, O. Petersen, J. Gray, M. Bissell (2007)
The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expressionMolecular Oncology, 1
F. Bertucci, P. Finetti, N. Cervera, E. Charafe-Jauffret, E. Mamessier, J. Adélaı̈de, S. Debono, G. Houvenaeghel, D. Maraninchi, P. Viens, C. Charpin, J. Jacquemier, D. Birnbaum (2006)
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.Cancer research, 66 9
R. Finn, J. Dering, C. Ginther, Cindy Wilson, Padraic Glaspy, N. Tchekmedyian, D. Slamon (2007)
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitroBreast Cancer Research and Treatment, 105
Pietenpol); CA68485 (core services); CA009385 (to
Xiaomei Liu, A. Gómez-Pinillos, A. Ferrari (2010)
Simultaneous targeting of the androgen receptor and PI3K/mTOR pathway in androgen-dependent and androgen-independent prostate cancer cells.Journal of Clinical Oncology, 28
S. Maira, F. Stauffer, J. Brueggen, P. Furet, C. Schnell, C. Fritsch, S. Brachmann, P. Chène, A. Pover, Kevin Schoemaker, D. Fabbro, Daniela Gabriel, M. Simonen, Leon Murphy, P. Finan, W. Sellers, C. García-echeverría (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activityMolecular Cancer Therapeutics, 7
E. Rakha, I. Ellis, J. Reis-Filho (2008)
Are Triple-Negative and Basal-Like Breast Cancer Synonymous?Clinical Cancer Research, 14
R. Dent, M. Trudeau, K. Pritchard, W. Hanna, H. Kahn, C. Sawka, L. Lickley, E. Rawlinson, P. Sun, S. Narod (2007)
Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 13
(2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerBreast Cancer Research : BCR, 12
T. Nielsen, Forrest Hsu, Kristin Jensen, Maggie Cheang, G. Karaca, Zhiyuan Hu, T. Hernandez-Boussard, C. Livasy, D. Cowan, L. Dressler, L. Akslen, J. Ragaz, A. Gown, C. Gilks, M. Rijn, C. Perou (2004)
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 10
Joshua Bauer, Fei Ye, C. Marshall, B. Lehmann, Christopher Pendleton, Y. Shyr, C. Arteaga, J. Pietenpol (2010)
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cellsBreast Cancer Research : BCR, 12
S. Ellard, M. Clemons, K. Gelmon, B. Norris, H. Kennecke, S. Chia, K. Pritchard, A. Eisen, T. Vandenberg, Marianne Taylor, E. Sauerbrei, M. Mishaeli, D. Huntsman, W. Walsh, M. Olivo, L. Mcintosh, L. Seymour (2009)
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 27
A. González-Angulo, K. Stemke‐Hale, S. Palla, M. Carey, R. Agarwal, Funda Meric-Berstam, T. Traina, C. Hudis, G. Hortobagyi, W. Gerald, G. Mills, B. Hennessy (2009)
Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast CancerClinical Cancer Research, 15
L. Mell, J. Dignam, J. Salama, E. Cohen, B. Polite, V. Dandekar, A. Bhate, M. Witt, D. Haraf, B. Mittal, E. Vokes, R. Weichselbaum (2010)
Predictors of competing mortality in advanced head and neck cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 1
S. Birrell, L. Butler, Jonathan Harris, Grant Buchanan, W. Tilley (2007)
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancerThe FASEB Journal, 21
A. Chakravarthy, M. Kelley, B. Mclaren, C. Truica, D. Billheimer, I. Mayer, A. Grau, David Johnson, J. Simpson, R. Beauchamp, Catherine Jones, J. Pietenpol (2006)
Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast CancerClinical Cancer Research, 12
(2003)
Lawton TJ. Androgen receptor expression in estrogen receptor-negative breast cancer
Xiaohong Yang, J. Chang-Claude, E. Goode, F. Couch, H. Nevanlinna, R. Milne, M. Gaudet, M. Schmidt, A. Broeks, A. Cox, P. Fasching, R. Hein, A. Spurdle, F. Blows, K. Driver, D. Flesch-Janys, J. Heinz, P. Sinn, A. Vrieling, T. Heikkinen, K. Aittomäki, P. Heikkilä, C. Blomqvist, J. Lissowska, B. Pepłońska, S. Chanock, J. Figueroa, L. Brinton, P. Hall, K. Czene, K. Humphreys, Hatef Darabi, Jianjun Liu, L. Veer, F. Leeuwen, I. Andrulis, G. Glendon, J. Knight, A. Mulligan, F. O'Malley, Nayana Weerasooriya, E. John, M. Beckmann, A. Hartmann, Sebastian Weihbrecht, D. Wachter, S. Jud, C. Loehberg, L. Baglietto, D. English, G. Giles, C. Mclean, G. Severi, D. Lambrechts, T. Vandorpe, C. Weltens, R. Paridaens, A. Smeets, P. Neven, H. Wildiers, Xianshu Wang, J. Olson, Victoria Cafourek, Z. Fredericksen, M. Kosel, C. Vachon, H. Cramp, D. Connley, S. Cross, S. Balasubramanian, M. Reed, T. Dörk, M. Bremer, A. Meyer, J. Karstens, Aysun Ay, T. Park-Simon, P. Hillemanns, J. Perez, Primitiva Rodríguez, P. Zamora, J. Benítez, Y. Ko, H. Fischer, U. Hamann, B. Pesch, T. Brüning, C. Justenhoven, H. Brauch, D. Eccles, W. Tapper, S. Gerty, E. Sawyer, I. Tomlinson, Angela Jones, M. Kerin, N. Miller, N. Mcinerney, H. Anton-Culver, A. Ziogas, Chen-Yang Shen, Chia-Ni Hsiung, Pei‐Ei Wu, Show‐Lin Yang, Jyh‐cherng Yu, Shou-Tung Chen, G. Hsu, C. Haiman, B. Henderson, L. Marchand, L. Kolonel, A. Lindblom, S. Margolin, A. Jakubowska, J. Lubiński, T. Huzarski, T. Byrski, B. Górski, J. Gronwald, M. Hooning, A. Hollestelle, A. Ouweland, A. Jager, M. Kriege, M. Tilanus-Linthorst, M. Collée, S. Wang-gohrke, K. Pylkäs, A. Jukkola-Vuorinen, K. Mononen, Mervi Grip, P. Hirvikoski, R. Winqvist, A. Mannermaa, V. Kosma, J. Kauppinen, V. Kataja, P. Auvinen, Y. Soini, R. Sironen, S. Bojesen, David Ørsted, D. Kaur-Knudsen, H. Flyger, B. Nordestgaard, Helene Holland, G. Chenevix-Trench, S. Manoukian, M. Barile, P. Radice, S. Hankinson, D. Hunter, R. Tamimi, S. Sangrajrang, P. Brennan, J. Mckay, F. Odefrey, V. Gaborieau, P. Devilee, Petra Huijts, R. Tollenaar, C. Seynaeve, G. Dite, C. Apicella, J. Hopper, F. Hammet, H. Tsimiklis, Letitia Smith, M. Southey, Manjeet Humphreys, D. Easton, P. Pharoah, M. Sherman, M. García-Closas (2011)
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.Journal of the National Cancer Institute, 103 3
Yang Li, L. Zou, Qiyuan Li, B. Haibe-Kains, Ruiyang Tian, Yan Li, C. Desmedt, C. Sotiriou, Z. Szallasi, J. Iglehart, Andrea Richardson, Z. Wang (2010)
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancerNature medicine, 16
M. Telli, J. Ford (2010)
Novel treatment approaches for triple-negative breast cancer.Clinical breast cancer, 10 Suppl 1
B. Boersma, M. Reimers, M. Yi, J. Ludwig, B. Luke, R. Stephens, H. Yfantis, D. Lee, J. Weinstein, S. Ambs (2008)
A stromal gene signature associated with inflammatory breast cancerInternational Journal of Cancer, 122
Y. Pawitan, J. Bjöhle, L. Amler, A. Borg, S. Egyházi, P. Hall, Xia Han, L. Holmberg, F. Huang, S. Klaar, E. Liu, L. Miller, H. Nordgren, A. Ploner, K. Sandelin, P. Shaw, J. Smeds, L. Skoog, S. Wedrén, J. Bergh (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsBreast Cancer Research, 7
A. Doane, M. Danso, P. Lal, M. Donaton, Liguo Zhang, C. Hudis, W. Gerald (2006)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgenOncogene, 25
Yixin Wang, J. Klijn, Yi Zhang, A. Sieuwerts, M. Look, Fei Yang, D. Talantov, M. Timmermans, M. Gelder, Jack Yu, T. Jatkoe, E. Berns, D. Atkins, J. Foekens (2005)
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 365
K. Stemke‐Hale, A. González-Angulo, A. Lluch, R. Neve, W. Kuo, M. Davies, M. Carey, Zhi Hu, Y. Guan, A. Sahin, W. Symmans, L. Pusztai, L. Nolden, H. Horlings, K. Berns, M. Hung, M. Vijver, V. Valero, J. Gray, R. Bernards, G. Mills, B. Hennessy (2008)
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.Cancer research, 68 15
C. Desmedt, F. Piette, S. Loi, Yixin Wang, F. Lallemand, B. Haibe-Kains, G. Viale, M. Delorenzi, Yi Zhang, M. D'assignies, J. Bergh, R. Lidereau, P. Ellis, A. Harris, J. Klijn, J. Foekens, F. Cardoso, M. Piccart, M. Buyse, C. Sotiriou (2007)
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation SeriesClinical Cancer Research, 13
F. Bertucci, P. Finetti, N. Cervera, B. Esterni, F. Hermitte, P. Viens, D. Birnbaum (2008)
How basal are triple‐negative breast cancers?International Journal of Cancer, 123
Marcus Schmidt, D. Böhm, C. Törne, E. Steiner, A. Puhl, H. Pilch, H. Lehr, J. Hengstler, H. Kölbl, M. Gehrmann (2008)
The humoral immune system has a key prognostic impact in node-negative breast cancer.Cancer research, 68 13
GL Bond, AJ Levine (2005)
A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphismBreast Cancer Research : BCR, 7
Sendurai Mani, Wenjun Guo, Mai-Jing Liao, E. Eaton, Ayyakkannu Ayyanan, A. Zhou, M. Brooks, Ferenc Reinhard, C. Zhang, M. Shipitsin, Lauren Campbell, K. Polyak, C. Brisken, Jing Yang, R. Weinberg (2008)
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 133
C. Chen, D. Welsbie, C. Tran, S. Baek, Randolph Chen, R. Vessella, M. Rosenfeld, C. Sawyers (2004)
Molecular determinants of resistance to antiandrogen therapyNature Medicine, 10
Sung-Young Shin, O. Rath, A. Zebisch, S. Choo, W. Kolch, Kwang-Hyun Cho (2010)
Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition.Cancer research, 70 17
M. Audeh, R. Penson, M. Friedlander, B. Powell, K. Bell-McGuinn, C. Scott, J. Weitzel, J. Carmichael, A. Tutt (2016)
Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15_suppl
C. Carmeci, E. deConinck, T. Lawton, D. Bloch, R. Weigel (1997)
Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimens is predictive of tumor biology.The American journal of pathology, 150 5
(2011)
Received for publication September 6, 2010, and accepted in revised form
A. Minn, G. Gupta, P. Siegel, Paula Bos, Weiping Shu, D. Giri, A. Viale, A. Olshen, W. Gerald, J. Massagué (2005)
Genes that mediate breast cancer metastasis to lungNature, 436
Olafur Stefansson, J. Jónasson, O. Johannsson, K. Ólafsdóttir, M. Steinarsdóttir, S. Valgeirsdóttir, J. Eyfjord (2009)
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypesBreast Cancer Research : BCR, 11
Michael Hayes, Dafydd Thomas, Agnieszka Emmons, T. Giordano, C. Kleer (2008)
Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the BreastClinical Cancer Research, 14
H. Farmer, N. Mccabe, C. Lord, A. Tutt, Damian Johnson, T. Richardson, M. Santarosa, Krystyna Dillon, I. Hickson, C. Knights, N. Martin, S. Jackson, G. Smith, A. Ashworth (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 434
G. Gibson, D. Qian, J. Ku, L. Lai (2005)
Metaplastic Breast Cancer: Clinical Features and OutcomesThe American Surgeon, 71
B. Marty, V. Maire, E. Gravier, G. Rigaill, A. Vincent-Salomon, Marion Kappler, I. Lebigot, Fathia Djelti, Audrey Tourdès, P. Gestraud, P. Hupé, E. Barillot, F. Cruzalegui, G. Tucker, M. Stern, J. Thiery, J. Hickman, T. Dubois (2008)
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cellsBreast Cancer Research : BCR, 10
B. Kreike, Marieke Kouwenhove, H. Horlings, B. Weigelt, H. Peterse, H. Bartelink, M. Vijver (2007)
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomasBreast cancer research : BCR, 9
D. Silver, A. Richardson, A. Eklund, Z. Wang, Z. Szallasi, Qiyuan Li, N. Juul, C. Leong, Diana Calogrias, Ayodele Buraimoh, Aquila Fatima, R. Gelman, P. Ryan, N. Tung, A. Nicolo, S. Ganesan, A. Miron, C. Colín, D. Sgroi, L. Ellisen, E. Winer, J. Garber (2010)
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 7
A. Teschendorff, A. Miremadi, S. Pinder, I. Ellis, C. Caldas (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancerGenome Biology, 8
Philip Jones, S. Altamura, Julia Boueres, F. Ferrigno, M. Fonsi, Claudia Giomini, S. Lamartina, E. Monteagudo, J. Ontoria, M. Orsale, M. Palumbi, S. Pesci, G. Roscilli, R. Scarpelli, Carsten Schultz-Fademrecht, C. Toniatti, M. Rowley (2009)
Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.Journal of medicinal chemistry, 52 22
C. Sotiriou, P. Wirapati, S. Loi, AdrianL. Harris, Steve Fox, J. Smeds, H. Nordgren, P. Farmer, Viviane Praz, B. Haibe-Kains, C. Desmedt, D. Larsimont, F. Cardoso, H. Peterse, D. Nuyten, M. Buyse, M. Vijver, J. Bergh, M. Piccart, M. Delorenzi (2006)
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.Journal of the National Cancer Institute, 98 4
B. MacDonald, K. Tamai, Xi He (2009)
Wnt/beta-catenin signaling: components, mechanisms, and diseases.Developmental cell, 17 1
(2007)
BMC Genomics BioMed Central
Yardena Samuels, Zhenghe Wang, A. Bardelli, N. Silliman, J. Ptak, Steve Szabo, Hai Yan, A. Gazdar, S. Powell, G. Riggins, J. Willson, S. Markowitz, K. Kinzler, B. Vogelstein, V. Velculescu (2004)
High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 304
J. Hoeijmakers (2001)
Genome maintenance mechanisms for preventing cancerNature, 411
Journal of Clinical Investigation – Unpaywall
Published: Jun 10, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.